MYC and diffuse large B-cell lymphoma: Notably, the proliferative phenotype of EZB-MYC+ DLBCLs is coupled to highly glycolytic metabolism and sustained protein and lipid synthesis in contrast to EZB-MYC- and other types of DLBCL (Wright et al., 2020).